MAPK4 and glioma: As shown in Figure 9D–F, MAPK4 expression was significantly positively correlated with expression of the main immunoinhibitory checkpoint molecules PD‐1, PD‐L1, HAVCR2, PDCD1LG2 and TIGIT in glioma.